Spiro Spireas, Ph.D.,
Chairman and Chief Executive Officer
Dr Spiro Spireas Dr. Spiro Spireas is the Chairman of the Board and Chief Executive Officer of Sigmapharm Laboratories, which he founded on March 1, 2005. His extensive academic and industrial background is an invaluable company asset. Dr. Spireas is the inventor and author of more than 70 international and domestic patents and 200 scientific papers, books, and other publications in the fields of industrial pharmacy, biopharmaceutics, pharmacokinetics, pharmaceutical technology and analytical chemistry. He holds Ph.D. and M.S. degrees in Pharmaceutics and Industrial Pharmacy from St. John's University, and a B.S. degree in Pharmacy from the Hellenic National University of Athens, Greece. Prior to forming Sigmapharm Laboratories, Dr. Spireas served for about 6 years as the Vice President of Research and Development for URL Pharma, Inc. (formerly URL/Mutual), where he developed various unique generic products including Felodipine extended release tablets which remained for about 4 years the only marketed generic equivalent to Astra Zeneca's Plendil ER tablets. Prior to this, Dr. Spireas was for about 7 years a Professor of Pharmacy and Pharmaceutical Technology at the Arnold & Marie Schwartz College of Pharmacy of Long Island University, where he taught several graduate and undergraduate courses of pharmaceutical sciences, consulted for the pharmaceutical and nutritional industries and conducted extensive research producing more than 20 Ph.D. and M.S. dissertations. In fact, several of his graduate students continued to work with Dr. Spireas as Sigmapharm personnel.
Kee Moore
Sr. Vice President Sales & Marketing
Kee Moore Kee Moore is the Senior Vice President of Sales and Marketing of Sigmapharm Laboratories, where he is responsible for achieving sales goals and initiatives while maximizing customer relationships.  Prior to Sigmapharm, Mr. Moore served as VP of Sales for Rising Pharmaceuticals, VP of National Accounts at Stada Pharmaceuticals, VP of Sales for Andrx Pharmaceuticals, Director of Sales for Teva Pharmaceuticals, VP of Sales for Biocraft Laboratories and Regional Sales Manager for Geneva Generics.  In all, Mr. Moore brings close to thirty years of generic pharmaceutical sales experience to Sigmapharm Laboratories.
Lokanath Lenka, M.Tech.,
Sr. Vice President Analytical Chemistry
Lokanath Lenka Lokanath Lenka is the Vice President of Analytical Chemistry of Sigmapharm Laboratories, where he is in charge of the company’s Analytical Operations. His more than 15 years of analytical experience along with his scientific, technical, regulatory and compliance expertise are invaluable company assets. Prior to joining the company in 2008, Mr. Lenka served at Perrigo Company from 2000 to 2008 in positions of increasing responsibility, most recently holding the position of Supervisor of Analytical R&D, at Caraco Pharmaceutical Laboratories from 1998 to 2000 and at Ranbaxy from 1996-1998. Mr. Lenka holds a M.Tech. degree in Analytical Chemistry from Indian Institute of Technology (IIT), New Delhi, India. He also holds a M.S. and B.S. degree in chemistry.